Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

251
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
251
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

212
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
212
Brain Imaging01:14

Brain Imaging

629
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
629
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

460
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
460
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

758
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
758

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum.

medRxiv : the preprint server for health sciences·2023
Same author

Consistency of Graph Theoretical Measurements of Alzheimer's Disease Fiber Density Connectomes Across Multiple Parcellation Scales.

Proceedings. IEEE International Conference on Bioinformatics and Biomedicine·2023
Same author

Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023
Same author

Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET.

medRxiv : the preprint server for health sciences·2023
Same author

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific.

Annals of neurology·2023
Same author

Integrative analysis of multi-omics and imaging data with incorporation of biological information via structural Bayesian factor analysis.

Briefings in bioinformatics·2023
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

751

阿尔茨海默氏症成像联盟

Debomoy K Lahiri1,2, Ruizhi Wang2, Bryan Maloney2

  • 1Indiana Alzheimer's Disease Research Center, Indianapolis, IN, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
概括
此摘要是机器生成的。

微RNA miR-153-3p可能是阿尔茨海默病 (AD) 和其他神经退行性疾病的主调节者. 这种微RNA (miRNA) 减少了像粉样蛋白前体蛋白 (APP) 和α-synuclein (SNCA) 等关键蛋白质,表明了治疗潜力.

更多相关视频

Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

相关实验视频

Last Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

751
Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

科学领域:

  • 神经科学是一个神经科学.
  • 遗传学 是一个遗传学.
  • 分子生物学分子生物学

背景情况:

  • 神经退行性疾病,包括阿尔茨海默病 (AD) 和莱维体痴呆症 (ADRD),共享复杂的病理途径.
  • 微RNAs (miRNAs) 是神经退行相关的生物过程的关键调节者.
  • 关键的病理特征包括粉样质斑块 (Aβ),神经纤维状结 (tau) 和α-synuclein (SNCA) 聚合,具有改变的抑制素1-沉默转录 (REST) 因子水平.

研究的目的:

  • 研究miR-153-3p在阿尔茨海默病 (AD) 风险中的作用.
  • 为了确定miR-153-3p是否调节关键的神经退行性蛋白质,包括粉样蛋白前体蛋白 (APP),α-synuclein (SNCA) 和REST.
  • 探索miR-153-3p及其遗传变异与AD风险和内分类型的关联.

主要方法:

  • 量化实时PCR (qRT-PCR) 用于测量非认知障碍 (NCI) 和AD受试者的死后脑组织中的miR-153水平.
  • 使用尸检脑组织和ADNI参与者基因定型进行了关联研究,以将miR-153-3p单核酸多态 (SNP) 与AD风险和内分类型联系起来.
  • 在体外研究中使用诱导多能干细胞 (iPSC) 衍生的神经元细胞和人类细胞系进行miRNA转染,以阐明miR-153-3p的作用机制.

主要成果:

  • 升高的miR-153-3p水平与阿尔茨海默病的可能性降低有关,而升高的REST水平与阿尔茨海默病的可能性增加相关.
  • 在miR-153基因中的遗传变异 (SNP) 与九种AD相关的内分类型有显著的关联.
  • miR-153-3p证明了降低REST,APP和SNCA的活性和蛋白质水平的能力,并影响了iPSC衍生的神经干细胞中的REST表达和神经元分化.
  • RNA测序,蛋白质组学和相互作用组分析确定了miR-153-3p在轴突引导通路中的参与.

结论:

  • miR-153-3p作为一种重要的调节剂,降低了关键的神经退行相关蛋白质 (如APP,SNCA和REST) 的表达.
  • 这些发现强调了miR-153-3p作为阿尔茨海默病 (AD) 和相关痴呆症 (ADRD) 的治疗标和生物标记物的潜力.
  • 未来的研究将包括在早期发病的AD病例中对miR-153进行分析,以进一步了解它在不同AD亚型中的作用.